controversy about whether naproxen is safer in patients with heart disease than other NSAIDs

March 2014

You'll hear controversy about whether naproxen is safer in patients with heart disease than other NSAIDs.

All NSAIDs have a "black box" warning about increased CV risk. This was added almost a decade ago after the withdrawal of Vioxx.

But CV risk isn't necessarily equal between NSAIDs.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote